CEO

Renee Gagnon

Gagnon is a serial startup founder, skilled at survival, stress and team building. She is both the first Transgender Publicly traded marijuana company CEO and the first female one. Renee built the core team of Thunderbird Biomedical, created and executed on the business plan and raised $3.7 M in funding then took the company public ($25M Valuation at IPO)… She went on to use this insight to create a diverse workforce with strong female leadership across the HollyWeed North Cannabis Inc ™. organization. After exiting Thunderbird Biomedical Inc in Jan 2015 as founding CEO and Board member, she has chosen to focus on US-based infrastructure and supply delivery for the Cannabis Industry with HollyWeed North Cannabis Inc™.